Complement-activating antineutrophil antibody in systemic lupus erythematosus.

Area of Science:

• Immunology
• Rheumatology
• Hematology

Background:

• Systemic lupus erythematosus (SLE) is an autoimmune disease.
• Neutropenia, a low neutrophil count, is a common complication in SLE.
• The role of autoantibodies and complement activation in SLE-related neutropenia requires further elucidation.

Purpose of the Study:

• To investigate the role of neutrophil-binding IgG and C3 fixation in patients with SLE.
• To determine the correlation between these immune markers and the presence and severity of neutropenia in SLE.

Main Methods:

• Serum samples from SLE patients were analyzed for IgG and C3 binding to neutrophils.
• Radioiodinated monoclonal anti-C3 antibody and staphylococcal protein A were used to quantify binding.
• Neutrophil counts were assessed and correlated with immune marker levels.

Main Results:

• SLE patient serum showed significantly higher IgG binding to neutrophils compared to normal serum, but this did not correlate with neutropenia.
• Serum from neutropenic SLE patients demonstrated significantly greater C3 fixation to neutrophils than non-neutropenic SLE patients.
• A strong negative correlation (r = -0.78) was observed between neutrophil count and serum C3-fixing ability.

Conclusions:

• Complement-activating monomeric antineutrophil IgG autoantibodies likely mediate C3 fixation to neutrophils in SLE.
• Antineutrophil antibody-mediated complement activation may be a key factor in the development of neutropenia in SLE patients.